The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 4×
“…the 92-item Symptom Questionnaire (SQ; Kellner 1987), the Beck Hopelessness Scale (BHS; Beck et al. 1974), the Beck Depression Inventory (BDI; Beck et al. 1961), the Patient Global Impression of Improvement (PGI-I; Guy 1976), and the Beck Anxiety Inventory (BAI; Beck et al. 1988) at the…”
MethodInfluentialHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 7×
“The remaining remitters (n = 132; 54.5% female; mean age 39.9 ± 10.3) to this acute phase treatment [remission = 17-item Hamilton Rating Scale for Depression (HAMD-17; Hamilton 1960 )] £7 for three consecutive weeks) were randomized to two, 28-week continuation phase treatment groups: (1) increase in fluoxetine to fix…”
MethodInfluentialAn inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · cited 4×
“Anxiety Inventory (BAI; Beck et al. 1988) at the conclusion of each study visit.”
BackgroundMethodInfluentialJournal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
(1976) · Medical Entomology and Zoology · Cited by 8,899
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
The measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · cited 4×
“BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; HAMD-17 = 17-item Hamilton Rating Scale for Depression; CGI-I = Clinical Global Impressions, Improvement; PGI-I = Patient Global Impressions, Improvement; CGI-S = Clinical Global Impressions, Severity; SQ = Symptom Questionnaire; BHS = Beck Hopelessness Sc…”
MethodInfluentialCognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236 · cited 11×
“Past research suggests that medication maintenance prevents recurrence (Fava and Kaji 1994; Keller et al. 1998), and the addition of CBT methods to medication maintenance confers a long-term treatment advantage (Paykel et al. 1999; Teasdale et al. 2000).”
BackgroundResultInfluentialThree-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Journal of Psychiatry and Neuroscience
(2025) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn · Cited by 1,128
Reynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659 · cited 2×
“Specifically, variants of CBT modified to specifically address residual symptoms in patients who have recovered from depression appear to be most efficacious in preventing relapse and recurrence (Segal et al 2002).”
BackgroundShea, M. T. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100026006 · Cited by 509 · cited 1×
“Other studies are consistent with our findings of no significant prophylactic effect of CT (Blackburn and Moore 1997; Frank et al. 1990; Shea et al. 1992).”
ResultPrevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491 · cited 1×
“In a study that evaluated WBT vs. CM during the continuation phase of treatment ( Fava et al. 1998c ), patients’ antidepressant medications were tapered after about three months into the continuation phase.”
BackgroundJudd, L. L., Akiskal, H. S., & Paulus, M. P. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00055-4 · Cited by 444 · cited 2×
“…of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 401, Boston, MA 02114, USA achieving full remission following the acute treatment phase (i.e., partial response with remaining residual symptoms) are at greater risk for both relapse and recurrence (Judd et al. 1997).”
Background(1987) · PubMed · Cited by 439
Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders
FAVA, G. A., RAFANELLI, C., CAZZARO, M., CONTI, S., & GRANDI, S. (1998) · Psychological Medicine · doi:10.1017/s0033291797006363 · Cited by 427 · cited 1×
“Modified forms of CBT, such as Well Being Therapy ( Fava et al. 1998a )o r MBCT (Teasdale et al. 2000) may be a better match for remitted patients.”
MethodBLACKBURN, I., EUNSON, K., & BISHOP, S. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90050-9 · Cited by 338
Six-Year Outcome for Cognitive Behavioral Treatment of Residual Symptoms in Major Depression
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1443 · Cited by 299
Jarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G. G., & Silver, P. C. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.381 · Cited by 293 · cited 2×
“However, the Jarrett et al. (2001) study does suggest a prophylactic effect of CT when compared with no treatment.”
ResultFAWCETT, J. A., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987) · PubMed · Cited by 273
Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications
FAVA, G. A. (1999) · Psychological Medicine · doi:10.1017/s0033291798007429 · Cited by 258
Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204
Self-citationKeller, M. B. (1998) · JAMA · doi:10.1001/jama.280.19.1665 · Cited by 184 · cited 2×
“Past research suggests that medication maintenance prevents recurrence (Fava and Kaji 1994; Keller et al. 1998), and the addition of CBT methods to medication maintenance confers a long-term treatment advantage (Paykel et al. 1999; Teasdale et al. 2000).”
BackgroundBlackburn, I.-M., & Moore, R. G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.4.328 · Cited by 179 · cited 2×
“Blackburn and Moore (1997) randomized 75 outpatients with recurrent major depression to three groups: 16 weeks of acute treatment and two years’ maintenance treatment with antidepressants and maintenance antidepressants; cognitive therapy and maintenance cognitive therapy; and antidepressants and…”
BackgroundResultKlein, D. N., Santiago, N. J., Vivian, D., Blalock, J. A., Kocsis, J. H., Markowitz, J. C., McCullough, J. P., Rush, A. J., Trivedi, M. H., Arnow, B. A., et al. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.681 · Cited by 138 · cited 2×
“To assess symptom change and therapeutic improvement, patients completed the 92-item Symptom Questionnaire (SQ; Kellner 1987 ), the Beck Hopelessness Scale (BHS; Beck et al. 1974), the Beck Depression Inventory (BDI; Beck et al. 1961), the Patient Global Impression of Improvement (PGI-I; Guy 1976), and the Beck Anxiet…”
BackgroundMethodInfluentialFava, M., Alpert, J., Nierenberg, A., Lagomasino, I., Sonawalla, S., Tedlow, J., Worthington, J., Baer, L., & Rosenbaum, J. F. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00008 · Cited by 131 · cited 1×
“The acute phase was an open, eight-week, fixed dose of fluoxetine at 20 mg/day (n = 391 patients; 55% female; mean age 39.8 ± 10.6; Fava et al. 2002).”
BackgroundInfluentialSelf-citationGroup Comparisons of DSM-IV Subtypes of Chronic Depression: Validity of the Distinctions, Part 2.
McCullough, J. P., Klein, D. N., Borian, F. E., Howland, R. H., Riso, L. P., Keller, M. B., & Banks, P. L. C. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.4.614 · Cited by 98
Gelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., Kornstein, S. G., Dunner, D. L., Markowitz, J. C., Hirschfeld, R. M. A., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01971-6 · Cited by 76 · cited 1×
“Gelenberg et al. (2003) examined recurrence rates in two maintenance treatment arms—nefazodone treatment (n = 76) and placebo only (n = 74).”
BackgroundPerlis, R. H., Nierenberg, A. A., Alpert, J. E., Pava, J., Matthews, J. D., Buchin, J., Sickinger, A. H., & Fava, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00006 · Cited by 73 · cited 3×
“Patients had previously achieved sustained remission through open acute and randomized continuation treatment, the results of which are described elsewhere (Perlis et al. 2002).”
BackgroundMethodSelf-citationSegal, Z., Vincent, P., & Levitt, A. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0246 · Cited by 70 · cited 2×
“Specifically, variants of CBT modified to specifically address residual symptoms in patients who have recovered from depression appear to be most efficacious in preventing relapse and recurrence (Segal et al 2002).”
BackgroundContinuation and Maintenance Treatments of Major Depressive Disorder
Fava, M., & Kaji, J. (1994) · Psychiatric Annals · doi:10.3928/0048-5713-19940601-07 · Cited by 46 · cited 5×
“Past research suggests that medication maintenance prevents recurrence (Fava and Kaji 1994; Keller et al. 1998), and the addition of CBT methods to medication maintenance confers a long-term treatment advantage (Paykel et al. 1999; Teasdale et al. 2000).”
BackgroundInfluentialPava, J. A., Fava, M., & Levenson, J. A. (1994) · Psychotherapy and Psychosomatics · doi:10.1159/000288892 · Cited by 33 · cited 2×
“Psychopharmacologists followed a standard protocol for medication management visits (Fawcett et al. 1987) and were instructed not to engage in cognitive or behavioral interventions (Pava et al. 1994).”
BackgroundSelf-citationPrevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20 · cited 3×
“For example, Paykel et al. (1999) randomized 158 patients who responded to acute phase pharmacotherapy but still reported residual symptoms to either 16 CBT sessions plus medication or to usual CM (medication only).”
Background
Research works printed but not linked: 2
- Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management: Imipramine/placebo administration manual. Psychopharmacology Bulletin, 23, 309–323.
- Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (1989). Structured clinical interview for DSM-III-R—Patient Edition (SCID-P, 9/1/89 Version). New York: Biometrics Research.
Cited by
Pryce, C. R., Azzinnari, D., Spinelli, S., Seifritz, E., Tegethoff, M., & Meinlschmidt, G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.006 · Cited by 241
Relapse and recurrence prevention in depression: Current research and future prospects
Beshai, S., Dobson, K. S., Bockting, C. L. H., & Quigley, L. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.09.003 · Cited by 165
“%) in comparison to control (62%), 1.32a (1.01–1.73) CT, AMD Petersen et al. (2010) N=52; Combined continuation CT+ADM (Fluoxetine) vs. ADM alone vs. CT+placebo vs. Placebo alone.”
BackgroundInfluentialVan Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Managing antidepressant discontinuation: a systematic review
Maund, E., Stuart, B., Moore, M., Dowrick, C., Geraghty, A. W. A., Dawson, S., & Kendrick, T. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2336 · Cited by 82
Rodgers, M., Asaria, M., Walker, S., McMillan, D., Lucock, M., Harden, M., Palmer, S., & Eastwood, A. (2012) · Health Technology Assessment · doi:10.3310/hta16280 · Cited by 68
Metadata
- Authors
- Petersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., & Fava, M.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Petersen, Timothy J.
- Venue
- Cognitive Therapy and Research
- Published
- 2007-10-01
- Volume
- 34
- Issue
- 1
- Pages
- 13-23
- ISSN
- 0147-5916 (ISSN-L)
- 1573-2819
- OpenAlex
- W2139752051
- Cited by
- 14
- References
- 36
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cognitive Therapy and Research (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- cognitive behavioral therapy, fluoxetine, major depressive disorder, recurrence prevention, maintenance therapy, remitted depression, continuation treatment, antidepressant treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.